Answers are grounded in this paper and cite their sources.
Background Vaccine hesitancy remains a persistent public health challenge, particularly in the post-COVID era. Understanding the demographic and psychosocial predictors of hesitancy is essential for designing targeted interventions to improve vaccine uptake. Methods This prospective cross-sectional study enrolled 632 adults aged 18–89 presenting for routine care at an academic medical center in Eastern Virginia over a 9-month period. Participants completed a REDCap survey incorporating the validated 32-item Multidimensional Vaccine Hesitancy Scale (MVHS), which captures eight domains of hesitancy. Internal consistency was assessed via Cronbach’s alpha and confirmatory factor analysis (CFA). Bivariate and multivariate linear regression analyses examined associations between demographic factors and mean vaccine hesitancy scores. Results The MVHS demonstrated excellent internal consistency (Cronbach’s α = 0.93) and good construct validity on CFA (RMSEA = 0.063; CFI = 0.92; TLI = 0.92). Cost and health risk concerns were the most frequently endorsed hesitancy domains. Younger age was negatively correlated with hesitancy across all eight domains, with forgetfulness showing the strongest association (rho = -0.28, p < 0.0001). Lower educational attainment was independently associated with higher hesitancy scores across all domains. On multivariate analysis, younger age and lower education remained significant independent predictors of higher mean vaccine hesitancy scores ( p < 0.05). Conclusions Vaccine hesitancy in this cohort was primarily driven by age and educational attainment rather than access barriers. Targeted educational outreach and behavioral interventions for younger, less formally educated populations may be most effective in improving vaccine uptake.
No takes yet. Share an insight, caveat, or question.
Nigro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: